Becker's ASC Review

42 Executive Briefing: more effectively understand and communicate the patient's condition and which treatment options might work best. "Having a robot assisting me in the operating room gives me a deeper understanding of each patient – even as I'm able to work more quickly," Dr. Miller added when asked about how the imaging and data analytics capabilities of ROSA affect his ability to personalize his approach to each patient. "Having a tool that lets you assess data pre- and intra-operatively ensures that you're as accurate as possible for each patient. This means that you can marry efficiency and reproducibility with the type of individual attention that makes patients undergoing these procedures truly feel the more personalized care they have received." In the ASC setting, this level of personalization may result in more satisfied patients and more predictable surgeries, both of which may make it possible for an ASC to treat more patients and see a measurable return on their investment in these technologies. Compatibility Matters ASCs typically have their own existing processes and it's important for a robotic system to seamlessly integrate into that workflow. "In my experience, the learning curve for robotics is actually quite low," said Dr. Miller. "Surgeons and staff quickly see the value of accuracy and reproducibility. This isn't about replacing any expertise or practice but refining it in a way that raises the standard of care across the board." "At Zimmer Biomet, we believe that a major driver in raising that standard are the insights that can be gleaned from data that carries across the patient journey and is critical to ensuring that surgeons and care teams can make the best possible decisions for patients," added Mr. Amiot. Earlier this year, Zimmer Biomet introduced a connected intelligence suite of integrated robotics and digital health technologies under a platform called ZBEdge. This offering of products runs the gamut from telehealth solutions to analytics platforms to robotics solutions. For instance, while ROSA provides exceptional support in the operating room, they have designed it to take advantage of other data- driven products and services like the company's clinical analytics platform OrthoIntel® Intelligence Platform and patient engagement services like mymobility® with Apple Watch®. With this connected suite of solutions, surgeons can access data insights from pre, intra- and post-surgery sources to truly understand what might be happening as a patient recovers and makes progress toward regaining their mobility. "Beyond this, our more than 45 years of clinical heritage in partial knee arthroplasty doesn't just mean that we know this space well, it means that we already have products that are clinically proven and trusted in ASCs across the country – whether it's our technology solutions, or our implants that surgeons already know and trust. With the new ROSA Partial Knee system, for instance, we have designed it for compatibility with Persona® Partial Knee, our clinically proven implant which has become a trusted solution for surgeons since it launched in 2017," said Mr. Amiot. Mr. Amiot also added that just as Zimmer Biomet wants to ensure that robotics enhance, not replace, surgeons and care teams that ASCs have invested in, the company also wants to make sure that they can work with the implants, devices and services that ASCs already know and trust. A Competitive Edge Technology is an ever-evolving process, and every ASC has its own budget, its own priorities, and its own timeline for making investments. It's important to note that when they do make that investment, it's sustainable and can grow with the practice and their patient demands. To that end, Zimmer Biomet provides multiple financing solutions for ASCs to acquire capital equipment, including ROSA Robotics, without significant cash outlay. "Robotics will become the standard in the next five years or so and those who do not make that transition will find it challenging to remain competitive," Dr. Miller said, referencing the increased demand for joint replacement procedures at ASCs. "Robotics are a capital expense that allows ASCs to grow, and it's becoming easier than ever to justify the spend as these systems become more robust. The issue will increasingly be not having a robot in an ASC, as more people see that these tools can result in greater patient satisfaction and a more efficient practice." To learn more about the ROSA Robotics System and how it can fit into your ASC, please visit ZimmerBiomet.com. n 1 United States Census Bureau. (2014 May 06) Fueled by Aging Baby Boomers, Nation's Older Population to Nearly Double in the Next 20 Years, Census Bureau Reports [Press release]. https://www.census.gov/ newsroom/press-releases/2014/cb1484.html#:~:text=%22The%20 United%20States%20is%20projected,Census%20Bureau's%20Popula- tion%20Projections%20Branch. This material is intended for healthcare professionals. Distribution to any other recipient is prohibited. Zimmer Biomet does not practice medicine. Patients must have a compatible smart phone to utilize mymobility. Not all patients are candidates for the use of this product and surgeons should evaluate individually to determine which patients are appropriate for therapy at home. All names used in the mymobility app examples are fictitious. No identification with actual patients or health care professionals is intended or should be inferred. iPhone and Apple Watch are trademarks of Apple Inc., registered in the U.S. and other countries. The Zimmer Biomet Connected Health mymobility Application. © 2021 Zimmer Biomet *Paid Zimmer Biomet Consultant Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

• Cover